Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
37.02
-0.18 (-0.48%)
At close: May 16, 2025, 4:00 PM
37.74
+0.72 (1.94%)
After-hours: May 16, 2025, 4:34 PM EDT
PRAX Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for PRAX stock ranges from a low of $28 to a high of $270. The average analyst price target of $116.5 forecasts a 214.69% increase in the stock price over the next year.
Price Target: $116.50 (+214.69%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 5 | 6 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +116.10% | May 7, 2025 |
| Wedbush | Wedbush | Sell Maintains $26 → $28 | Sell | Maintains | $26 → $28 | -24.37% | May 5, 2025 |
| Needham | Needham | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +116.10% | May 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +183.63% | May 1, 2025 |
| Needham | Needham | Strong Buy Reiterates $85 | Strong Buy | Reiterates | $85 | +129.61% | Apr 8, 2025 |
Financial Forecast
Revenue This Year
1.36M
from 8.55M
Decreased by -84.06%
Revenue Next Year
12.13M
from 1.36M
Increased by 789.73%
EPS This Year
-12.58
from -10.21
EPS Next Year
-12.14
from -12.58
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.0M | 70.4M | 186.2M | ||
| Avg | 1.4M | 12.1M | 69.3M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.6% | 5,068.4% | 1,435.7% | ||
| Avg | -84.1% | 789.7% | 471.4% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -10.49 | -8.88 | -6.98 | ||
| Avg | -12.58 | -12.14 | -10.92 | ||
| Low | -14.83 | -18.61 | -16.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.